Supporters of the 21st Century Cures bill want to use the expiring rare pediatric disease priority review voucher (PRV) as a way to push the legislation up Congress' priority list this month, but it is appearing increasingly unlikely, however, which could force advocates to find another vehicle to ensure the program continues.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?